biotech

Why Proteostasis Shares Are Exploding

Proteostasis Therapeutics Inc. (NASDAQ: PTI) shares absolutely exploded in Tuesday’s session, more than doubling after the firm reported positive results from its cystic fibrosis (CF) study. These positive study results ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, November 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Will Consumers Trust Generic Viagra?

If there is one drug from pharmaceutical giants that may have changed the world in lifestyle, Viagra might be the first one that comes to mind. It has helped millions ...
Read Full Story »

Blueprint Medicines Wins Big in Early-Stage Trial

Blueprint Medicines Corp. (NASDAQ: BPMC) watched its shares make a solid gain on Monday morning after the firm announced results for its ongoing early-stage trial for advanced systemic mastocytosis (SM). ...
Read Full Story »

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

With the U.S. House and the Senate now working together to patch up differences between the two tax reform bills, one thing looks pretty certain: In one shape or another, ...
Read Full Story »

Denali Therapeutics Enters the Market With a Bang

Denali Therapeutics Inc. (NASDAQ: DNLI) entered the markets with a bang on Friday. In its initial public offering (IPO), the company priced its 13.89 million shares at $18 apiece, within ...
Read Full Story »

Radius Health Breast Cancer Trial Continues to Show Progress

Radius Health Inc. (NASDAQ: RDUS) shares climbed higher on Friday after the firm provided an update on its early-stage clinical study in patients with estrogen receptor positive (ER+) breast cancer. ...
Read Full Story »

Is This the Turnaround SteadyMed Has Waited For?

SteadyMed Ltd. (NASDAQ: STDY) shares made an incredibly gain to close out the week, after a positive meeting with the U.S. Food and Drug Administration (FDA). Specifically, the firm said ...
Read Full Story »

Will Alexion Pharmaceuticals Fight This Activist?

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) shares saw a handy gain early on Friday after the New York Times reported that there might be some increasing activist movement in the stock. ...
Read Full Story »

Could Sage Therapeutics’ Depression Drug Be the Next Big Thing?

Shares of Sage Therapeutics Inc. (NASDAQ: SAGE) saw an incredible gain on Thursday after the firm announced positive top-line results from its midstage trial. Specifically, the firm reported results from ...
Read Full Story »

Arrowhead Pharma Wins in Midstage Hepatitis Study

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) saw its shares make a handy gain early Wednesday after the firm presented new data from its midstage study for the treatment of hepatitis B ...
Read Full Story »

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

With 2017 coming to an end, investors are wondering how they should be investing for 2018 and beyond. At the start of December, the Dow was up just over 20% ...
Read Full Story »

Revance Scores Solid Results in Late-Stage Trial

Shares of Revance Therapeutics Inc. (NASDAQ: RVNC) saw a solid gain early on Tuesday after the company announced positive top-line results from its late-stage trials. Specifically, the firm’s next-generation neuromodulator ...
Read Full Story »

Jefferies Has 4 Red-Hot Biotech Stock Picks for December

Barring a huge meltdown, the S&P 500 will once again have a double-digit year of gains, and most investors should be looking at their 401(k)s and other accounts with some ...
Read Full Story »

Quanterix Closes in on IPO

Quanterix has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) in regards to its initial public offering (IPO). The company intends to price its 3.34 ...
Read Full Story »